DAA2372 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB5 |
64.1% Increase Gene Expression Level |
|
DAA2362 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB5 |
184.0% Increase Gene Expression Level |
|
DAA2164 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
parietal lobe |
Human |
HLA-DRB6 |
33.5% Increase Gene Expression Level |
|
DAA2163 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB6 |
150.2% Increase Gene Expression Level |
|
DAA2350 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
32.2% Increase Gene Expression Level |
|
DAA2335 |
major histocompatibility complex, class I-related increases with age |
Molecular |
hippocampus |
Human |
MR1 |
46.6% Increase Gene Expression Level |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
22.4% Increase Gene Expression Level |
|
DAA135 |
malate dehydrogenase 1, NAD (soluble) |
Molecular |
brain |
Human |
MDH1 |
4.0% Decrease Gene Expression Level |
|
DAA136 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
Molecular |
brain |
Human |
ME3 |
5.0% Decrease Gene Expression Level |
|
DAA1416 |
mannose-P-dolichol utilization defect 1 |
Molecular |
hippocampus |
Mouse |
Mpdu1 |
3.0% Increase Gene Expression Level |
|
DAA1267 |
MAS-related GPR, member A4 |
Molecular |
brain |
Mouse |
Mrgpra4 |
92.0% Decrease Gene Expression Level |
|
DAA731 |
Mean diffusivity increases and water diffusion anisotropy decreases |
Physiological |
corpus callosum, white matter |
Human |
— |
— |
|
DAA731 |
Mean diffusivity increases and water diffusion anisotropy decreases |
Physiological |
corpus callosum, white matter |
Human |
— |
— |
|
DAA86 |
mechanistic target of rapamycin (serine/threonine kinase) |
Molecular |
brain |
Human |
MTOR |
7.0% Decrease Gene Expression Level |
|
DAA780 |
Medial temporal activation during encoding and retrieval of memory is reduced |
Physiological |
brain |
Human |
— |
— |
|
DAA139 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
Molecular |
brain |
Human |
MLC1 |
10.0% Increase Gene Expression Level |
|
DAA1945 |
Memory consolidation is impaired |
Psychological |
brain |
Mouse |
— |
— |
|
DAA754 |
Memory impairment |
Psychological |
brain |
Human |
— |
— |
|
DAA1051 |
Mental Health (psychological distress) (Female) |
Pathological |
brain |
Human |
— |
SeriesIncidence |
|
DAA1050 |
Mental Health (psychological distress) (Male) |
Pathological |
brain |
Human |
— |
SeriesIncidence |
|
DAA143 |
metallothionein 1E |
Molecular |
brain |
Human |
MT1E |
10.0% Increase Gene Expression Level |
|
DAA1266 |
methyltransferase like 2 |
Molecular |
brain |
Mouse |
Mettl2 |
5.0% Decrease Gene Expression Level |
|
DAA2348 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
37.9% Increase Gene Expression Level |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
39.5% Increase Gene Expression Level |
|
DAA2340 |
MHC class I polypeptide-related sequence B increases with age |
Molecular |
parietal lobe |
Human |
MICB |
39.9% Increase Gene Expression Level |
|